SlideShare a Scribd company logo
Selected Zoonotic Diseases  Conference Call August 5, 2009
Pierre Rollin, MD; Division of Viral and Rickettsial Diseases, CDC; 404-639-1124; prollin@cdc.gov Selected Zoonotic Diseases  Conference Call August 5, 2009 Update: Ebola-Reston in the Philippines
Kendra E. Stauffer, DVM; Division of Foodborne, Bacterial, and Mycotic Diseases, CDC; 404-639-3435; kstauffer@cdc.gov Selected Zoonotic Diseases  Conference Call August 5, 2009 The Changing Face of Brucellosis in the United States
Kelly K. Stimpert, MPH, PhD candidate;  Division of Parasitic Diseases;  770-488-4968; kkstimpert@cdc.gov Selected Zoonotic Diseases  Conference Call August 5, 2009 Update on Chagas disease in the United States
Update on Chagas Disease in the United States  Kelly Stimpert, MPH [email_address] AREF Health Communication Specialist Centers for Disease Control and Prevention Division of Parasitic Diseases
Chagas disease ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Trypanosoma cruzi  lifecycle
Clinical diagnosis of Chagas disease ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical Chagas disease ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Who is at risk in the U.S. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Source:  Schmunis Mem Inst Osw Cruz 2007 18 million people in the U.S. born in Mexico, Central and South America
Chagas disease in the United States ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],* Bern and Montgomery, CID 2009
FDA approves first blood donation screening assay December 2006 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Confirmed positive blood donors 2007 – 2009*, n = 940 *Source: AABB Biovigilance program, as of July 31, 2009 ,[object Object]
Are healthcare providers aware of  Chagas disease? ,[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment drug availability in United States ,[object Object],[object Object],[object Object],[object Object]
Chagas disease online resources  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Thanks to ,[object Object],[object Object],[object Object],[object Object],[object Object],Dr. Carlos Chagas
Jesse Blanton, MPH; Division of Viral and Rickettsial Diseases (DVRD), CDC;  404-639-2289; jblanton@cdc.gov;  Christopher Cox, MS; DVRD, CDC;  404-639-0045; cmcox1@cdc.gov Peter J. Costa, MPH CHES;  Alliance for Rabies Control; 919-830-2199; peter.costa@worldrabiesday.org  Selected Zoonotic Diseases  Conference Call August 5, 2009 ,[object Object],[object Object],[object Object]
World Rabies Day ,[object Object],[object Object],[object Object],[object Object]
World Rabies Day ,[object Object],[object Object],[object Object]
World Rabies Day ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
World Rabies Day ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
World Rabies Day ,[object Object],[object Object],[object Object],[object Object]
World Rabies Day ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
World Rabies Day ,[object Object],[object Object],[object Object],[object Object],[object Object]
World Rabies Day: Why is it so important?
 
 
[object Object],[object Object],[object Object],[object Object],[object Object],U.S. Web Visitors by State Google Analytics Measuring Impact 2007 & 2008
Organizational Partners
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Get Involved – WRD 2009
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Howard Pue, DVM, MSVPM;  State Public Health Veterinarian, Missouri;  573-751-6117; howard.pue@dhss.mo.gov Selected Zoonotic Diseases  Conference Call August 5, 2009 Missouri Rabies/Tetanus Symposium
Emily Zielinski-Gutierrez, MPH, DRPH;  Division of Vector-borne Infectious Diseases, CDC; 970-221-6477; EZielinskiGutierrez@cdc.gov Selected Zoonotic Diseases  Conference Call August 5, 2009 Update: West Nile
Selected Zoonotic Diseases  Conference Call August 5, 2009

More Related Content

What's hot

04.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 202004.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 2020
UC San Diego AntiViral Research Center
 
Safety and Success in a Post-Pandemic Society - Daniela Accurso, MD, MPH - 7...
Safety and Success in a Post-Pandemic Society -  Daniela Accurso, MD, MPH - 7...Safety and Success in a Post-Pandemic Society -  Daniela Accurso, MD, MPH - 7...
Safety and Success in a Post-Pandemic Society - Daniela Accurso, MD, MPH - 7...
Summit Health
 
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
UC San Diego AntiViral Research Center
 
Countdown: Confronting the HIV/HCV Coinfection Crisis
Countdown: Confronting the HIV/HCV Coinfection CrisisCountdown: Confronting the HIV/HCV Coinfection Crisis
Countdown: Confronting the HIV/HCV Coinfection Crisis
Harm Reduction Coalition
 
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
UC San Diego AntiViral Research Center
 
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
UC San Diego AntiViral Research Center
 
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
UC San Diego AntiViral Research Center
 
coronavirus | The United States infected is maybe over 20 million
coronavirus | The United States infected is maybe over 20 millioncoronavirus | The United States infected is maybe over 20 million
coronavirus | The United States infected is maybe over 20 million
Top Pure Health TPH
 
Immunocompromised hosts and transplant recipients
Immunocompromised hosts and transplant recipientsImmunocompromised hosts and transplant recipients
Immunocompromised hosts and transplant recipients
UCSFGlobalHealthSciences
 
Interpreting genomic variation and phylogenetic trees to understand disease t...
Interpreting genomic variation and phylogenetic trees to understand disease t...Interpreting genomic variation and phylogenetic trees to understand disease t...
Interpreting genomic variation and phylogenetic trees to understand disease t...
Jennifer Gardy
 
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
UC San Diego AntiViral Research Center
 
USA: Hepatitis A infections rise by nearly 300%
USA: Hepatitis A infections rise by nearly 300%USA: Hepatitis A infections rise by nearly 300%
USA: Hepatitis A infections rise by nearly 300%
Δρ. Γιώργος K. Κασάπης
 
Heaptitis a respuesta
Heaptitis a respuestaHeaptitis a respuesta
Heaptitis a respuesta
Beatles180681
 
09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals
UC San Diego AntiViral Research Center
 
Testing for Acute HIV and Early Initiation of ART
Testing for Acute HIV and Early Initiation of ARTTesting for Acute HIV and Early Initiation of ART
Testing for Acute HIV and Early Initiation of ART
HopkinsCFAR
 
Clinical Impact of Data From the CROI 2015,Seattle
Clinical Impact of Data From the CROI 2015,SeattleClinical Impact of Data From the CROI 2015,Seattle
Clinical Impact of Data From the CROI 2015,Seattle
Hivlife Info
 
Infection Control in Countries with Limited Resources
Infection Control in Countries with Limited Resources Infection Control in Countries with Limited Resources
Infection Control in Countries with Limited Resources
icsp
 
Integrating Recent Data When Selecting First-line Antiretroviral Therapy.2015...
Integrating Recent Data When Selecting First-line Antiretroviral Therapy.2015...Integrating Recent Data When Selecting First-line Antiretroviral Therapy.2015...
Integrating Recent Data When Selecting First-line Antiretroviral Therapy.2015...
Hivlife Info
 
Why is autoimmune disease underserved
Why is autoimmune disease underservedWhy is autoimmune disease underserved
Why is autoimmune disease underserved
DrBonnie360
 
HIV:AIDS-Latino
HIV:AIDS-LatinoHIV:AIDS-Latino
HIV:AIDS-Latino
Elena Kennedy
 

What's hot (20)

04.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 202004.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 2020
 
Safety and Success in a Post-Pandemic Society - Daniela Accurso, MD, MPH - 7...
Safety and Success in a Post-Pandemic Society -  Daniela Accurso, MD, MPH - 7...Safety and Success in a Post-Pandemic Society -  Daniela Accurso, MD, MPH - 7...
Safety and Success in a Post-Pandemic Society - Daniela Accurso, MD, MPH - 7...
 
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
 
Countdown: Confronting the HIV/HCV Coinfection Crisis
Countdown: Confronting the HIV/HCV Coinfection CrisisCountdown: Confronting the HIV/HCV Coinfection Crisis
Countdown: Confronting the HIV/HCV Coinfection Crisis
 
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
 
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
 
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
 
coronavirus | The United States infected is maybe over 20 million
coronavirus | The United States infected is maybe over 20 millioncoronavirus | The United States infected is maybe over 20 million
coronavirus | The United States infected is maybe over 20 million
 
Immunocompromised hosts and transplant recipients
Immunocompromised hosts and transplant recipientsImmunocompromised hosts and transplant recipients
Immunocompromised hosts and transplant recipients
 
Interpreting genomic variation and phylogenetic trees to understand disease t...
Interpreting genomic variation and phylogenetic trees to understand disease t...Interpreting genomic variation and phylogenetic trees to understand disease t...
Interpreting genomic variation and phylogenetic trees to understand disease t...
 
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
 
USA: Hepatitis A infections rise by nearly 300%
USA: Hepatitis A infections rise by nearly 300%USA: Hepatitis A infections rise by nearly 300%
USA: Hepatitis A infections rise by nearly 300%
 
Heaptitis a respuesta
Heaptitis a respuestaHeaptitis a respuesta
Heaptitis a respuesta
 
09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals
 
Testing for Acute HIV and Early Initiation of ART
Testing for Acute HIV and Early Initiation of ARTTesting for Acute HIV and Early Initiation of ART
Testing for Acute HIV and Early Initiation of ART
 
Clinical Impact of Data From the CROI 2015,Seattle
Clinical Impact of Data From the CROI 2015,SeattleClinical Impact of Data From the CROI 2015,Seattle
Clinical Impact of Data From the CROI 2015,Seattle
 
Infection Control in Countries with Limited Resources
Infection Control in Countries with Limited Resources Infection Control in Countries with Limited Resources
Infection Control in Countries with Limited Resources
 
Integrating Recent Data When Selecting First-line Antiretroviral Therapy.2015...
Integrating Recent Data When Selecting First-line Antiretroviral Therapy.2015...Integrating Recent Data When Selecting First-line Antiretroviral Therapy.2015...
Integrating Recent Data When Selecting First-line Antiretroviral Therapy.2015...
 
Why is autoimmune disease underserved
Why is autoimmune disease underservedWhy is autoimmune disease underserved
Why is autoimmune disease underserved
 
HIV:AIDS-Latino
HIV:AIDS-LatinoHIV:AIDS-Latino
HIV:AIDS-Latino
 

Viewers also liked

John R. Gustafson P.E.'s Resume
John R. Gustafson P.E.'s ResumeJohn R. Gustafson P.E.'s Resume
John R. Gustafson P.E.'s Resume
John Gustafson
 
Grand Plaza Hotel
Grand Plaza HotelGrand Plaza Hotel
Grand Plaza Hotel
guest54e5b6d
 
CD+M PPT 2011
CD+M PPT 2011CD+M PPT 2011
CD+M PPT 2011
Marc_Rosenberg
 
Portfolio Felix Barros 2005-2008
Portfolio Felix Barros 2005-2008Portfolio Felix Barros 2005-2008
Portfolio Felix Barros 2005-2008
Félix Barros Ribalta
 
Félix Barros - Mi historia de emprendimiento
Félix Barros - Mi historia de emprendimientoFélix Barros - Mi historia de emprendimiento
Félix Barros - Mi historia de emprendimiento
Félix Barros Ribalta
 
fanear, THE app for music shows
fanear, THE app for music showsfanear, THE app for music shows
fanear, THE app for music shows
Félix Barros Ribalta
 
Modelos de negocio TIC's
Modelos de negocio TIC'sModelos de negocio TIC's
Modelos de negocio TIC's
Félix Barros Ribalta
 
Marriott International, Inc. France PR Strategy
Marriott International, Inc. France PR StrategyMarriott International, Inc. France PR Strategy
Marriott International, Inc. France PR Strategy
kb302906
 
La historia de Rulete
La historia de RuleteLa historia de Rulete
La historia de Rulete
Félix Barros Ribalta
 
felix barros: PORTFOLIO.EXPERIENCE.METHOD
felix barros: PORTFOLIO.EXPERIENCE.METHODfelix barros: PORTFOLIO.EXPERIENCE.METHOD
felix barros: PORTFOLIO.EXPERIENCE.METHOD
Félix Barros Ribalta
 
10 REASONS Why Your Startup Should Come To Viña del Mar Rather Than Santiago
10 REASONS Why Your Startup Should Come To Viña del Mar Rather Than Santiago10 REASONS Why Your Startup Should Come To Viña del Mar Rather Than Santiago
10 REASONS Why Your Startup Should Come To Viña del Mar Rather Than Santiago
Félix Barros Ribalta
 
The Ambiguity of Beauty
The Ambiguity of BeautyThe Ambiguity of Beauty
The Ambiguity of Beauty
kb302906
 
Great Bear Rainforest
Great Bear RainforestGreat Bear Rainforest
Great Bear Rainforest
ClaudineG
 
RASU V Región 2012
RASU V Región 2012RASU V Región 2012
RASU V Región 2012
Félix Barros Ribalta
 
западно поморавље
западно поморављезападно поморавље
западно поморављеfiki196
 
7351039 Pharma Gapuz Intro
7351039 Pharma Gapuz Intro7351039 Pharma Gapuz Intro
7351039 Pharma Gapuz Intro
Jerico Mungcal
 
SonicPollen @ Progress Day - Startup Chile
SonicPollen @ Progress Day - Startup ChileSonicPollen @ Progress Day - Startup Chile
SonicPollen @ Progress Day - Startup Chile
Félix Barros Ribalta
 
Rattan, bamboo presentation
Rattan, bamboo presentationRattan, bamboo presentation
Rattan, bamboo presentation
Linh Mai
 
Marriott Competitor Analysis
Marriott Competitor AnalysisMarriott Competitor Analysis
Marriott Competitor Analysis
kb302906
 

Viewers also liked (19)

John R. Gustafson P.E.'s Resume
John R. Gustafson P.E.'s ResumeJohn R. Gustafson P.E.'s Resume
John R. Gustafson P.E.'s Resume
 
Grand Plaza Hotel
Grand Plaza HotelGrand Plaza Hotel
Grand Plaza Hotel
 
CD+M PPT 2011
CD+M PPT 2011CD+M PPT 2011
CD+M PPT 2011
 
Portfolio Felix Barros 2005-2008
Portfolio Felix Barros 2005-2008Portfolio Felix Barros 2005-2008
Portfolio Felix Barros 2005-2008
 
Félix Barros - Mi historia de emprendimiento
Félix Barros - Mi historia de emprendimientoFélix Barros - Mi historia de emprendimiento
Félix Barros - Mi historia de emprendimiento
 
fanear, THE app for music shows
fanear, THE app for music showsfanear, THE app for music shows
fanear, THE app for music shows
 
Modelos de negocio TIC's
Modelos de negocio TIC'sModelos de negocio TIC's
Modelos de negocio TIC's
 
Marriott International, Inc. France PR Strategy
Marriott International, Inc. France PR StrategyMarriott International, Inc. France PR Strategy
Marriott International, Inc. France PR Strategy
 
La historia de Rulete
La historia de RuleteLa historia de Rulete
La historia de Rulete
 
felix barros: PORTFOLIO.EXPERIENCE.METHOD
felix barros: PORTFOLIO.EXPERIENCE.METHODfelix barros: PORTFOLIO.EXPERIENCE.METHOD
felix barros: PORTFOLIO.EXPERIENCE.METHOD
 
10 REASONS Why Your Startup Should Come To Viña del Mar Rather Than Santiago
10 REASONS Why Your Startup Should Come To Viña del Mar Rather Than Santiago10 REASONS Why Your Startup Should Come To Viña del Mar Rather Than Santiago
10 REASONS Why Your Startup Should Come To Viña del Mar Rather Than Santiago
 
The Ambiguity of Beauty
The Ambiguity of BeautyThe Ambiguity of Beauty
The Ambiguity of Beauty
 
Great Bear Rainforest
Great Bear RainforestGreat Bear Rainforest
Great Bear Rainforest
 
RASU V Región 2012
RASU V Región 2012RASU V Región 2012
RASU V Región 2012
 
западно поморавље
западно поморављезападно поморавље
западно поморавље
 
7351039 Pharma Gapuz Intro
7351039 Pharma Gapuz Intro7351039 Pharma Gapuz Intro
7351039 Pharma Gapuz Intro
 
SonicPollen @ Progress Day - Startup Chile
SonicPollen @ Progress Day - Startup ChileSonicPollen @ Progress Day - Startup Chile
SonicPollen @ Progress Day - Startup Chile
 
Rattan, bamboo presentation
Rattan, bamboo presentationRattan, bamboo presentation
Rattan, bamboo presentation
 
Marriott Competitor Analysis
Marriott Competitor AnalysisMarriott Competitor Analysis
Marriott Competitor Analysis
 

Similar to August 2009 CDC Selected Zoonotic Diseases Conference Call

February 2010 Selected Zoonotic Diseases Conference Call
February 2010 Selected Zoonotic Diseases Conference CallFebruary 2010 Selected Zoonotic Diseases Conference Call
February 2010 Selected Zoonotic Diseases Conference Call
goa4
 
February 2010 Selected Zoonotic Diseases Conference Call
February 2010 Selected Zoonotic Diseases Conference CallFebruary 2010 Selected Zoonotic Diseases Conference Call
February 2010 Selected Zoonotic Diseases Conference Call
goa4
 
Dr. Benjamin Park - Antimicrobial Resistance in Humans and the Global Health ...
Dr. Benjamin Park - Antimicrobial Resistance in Humans and the Global Health ...Dr. Benjamin Park - Antimicrobial Resistance in Humans and the Global Health ...
Dr. Benjamin Park - Antimicrobial Resistance in Humans and the Global Health ...
John Blue
 
Food Safety Winnable Battle presentation
Food Safety Winnable Battle presentationFood Safety Winnable Battle presentation
Food Safety Winnable Battle presentation
PublicHealthFoundation
 
Pandemic Flu Health Information and Work Flow Project - Sunil Nair Health Inf...
Pandemic Flu Health Information and Work Flow Project - Sunil Nair Health Inf...Pandemic Flu Health Information and Work Flow Project - Sunil Nair Health Inf...
Pandemic Flu Health Information and Work Flow Project - Sunil Nair Health Inf...
Sunil Nair
 
PERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPE
PERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPEPERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPE
PERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPE
WAidid
 
09-rwcc18-sherman-keyslides.pptx
09-rwcc18-sherman-keyslides.pptx09-rwcc18-sherman-keyslides.pptx
09-rwcc18-sherman-keyslides.pptx
dinamikhealthcare
 
January 2010 Selected Zoonotic Diseases Conference Call
January 2010 Selected Zoonotic Diseases Conference Call January 2010 Selected Zoonotic Diseases Conference Call
January 2010 Selected Zoonotic Diseases Conference Call
goa4
 
Intro to Infectious Diseases and Epidemiology of Nosocomial Infection
Intro to Infectious Diseases and Epidemiology of Nosocomial InfectionIntro to Infectious Diseases and Epidemiology of Nosocomial Infection
Intro to Infectious Diseases and Epidemiology of Nosocomial Infection
Philippine Hospital Infection Contol Nurses Associaton (PHICNA) Inc.
 
CDC July 2009 Selected Zoonotic Diseases Conference Call
CDC July 2009 Selected Zoonotic Diseases Conference CallCDC July 2009 Selected Zoonotic Diseases Conference Call
CDC July 2009 Selected Zoonotic Diseases Conference Call
goa4
 
World AIDS Day 2014 HIV and AIDS Awareness Campaigns
World AIDS Day 2014 HIV and AIDS Awareness CampaignsWorld AIDS Day 2014 HIV and AIDS Awareness Campaigns
World AIDS Day 2014 HIV and AIDS Awareness Campaigns
Patricia "Leigh" Allen, BJ, MPA, MPH
 
Batten oss 727 -bw changes
Batten oss 727 -bw changesBatten oss 727 -bw changes
Batten oss 727 -bw changes
Open Science Summit
 
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Canadian Organization for Rare Disorders
 
Tackling the U.S. Healthcare System’s Infectious Disease Management Problem
Tackling the U.S. Healthcare System’s Infectious Disease Management ProblemTackling the U.S. Healthcare System’s Infectious Disease Management Problem
Tackling the U.S. Healthcare System’s Infectious Disease Management Problem
Viewics
 
Dr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
Dr. James Hughes - Combating Antimicrobial Resistance: The Way ForwardDr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
Dr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
John Blue
 
When reducing cancer risk in our population, let’s not exacerbate disparities
When reducing cancer risk in our population, let’s not exacerbate disparitiesWhen reducing cancer risk in our population, let’s not exacerbate disparities
When reducing cancer risk in our population, let’s not exacerbate disparities
Graham Colditz
 
JTC300_Final Report_Goin
JTC300_Final Report_GoinJTC300_Final Report_Goin
JTC300_Final Report_Goin
Alyssa Goin
 
GUH_ALICE_-_Indiana_Leadership_Conference.ppt
GUH_ALICE_-_Indiana_Leadership_Conference.pptGUH_ALICE_-_Indiana_Leadership_Conference.ppt
GUH_ALICE_-_Indiana_Leadership_Conference.ppt
karthik595455
 
Trend & Strategies for Prevention of Healthcare-associated Infections
Trend & Strategies for Prevention of Healthcare-associated InfectionsTrend & Strategies for Prevention of Healthcare-associated Infections
Trend & Strategies for Prevention of Healthcare-associated Infections
unitkawalaninfeksihi
 
The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center
UC San Diego AntiViral Research Center
 

Similar to August 2009 CDC Selected Zoonotic Diseases Conference Call (20)

February 2010 Selected Zoonotic Diseases Conference Call
February 2010 Selected Zoonotic Diseases Conference CallFebruary 2010 Selected Zoonotic Diseases Conference Call
February 2010 Selected Zoonotic Diseases Conference Call
 
February 2010 Selected Zoonotic Diseases Conference Call
February 2010 Selected Zoonotic Diseases Conference CallFebruary 2010 Selected Zoonotic Diseases Conference Call
February 2010 Selected Zoonotic Diseases Conference Call
 
Dr. Benjamin Park - Antimicrobial Resistance in Humans and the Global Health ...
Dr. Benjamin Park - Antimicrobial Resistance in Humans and the Global Health ...Dr. Benjamin Park - Antimicrobial Resistance in Humans and the Global Health ...
Dr. Benjamin Park - Antimicrobial Resistance in Humans and the Global Health ...
 
Food Safety Winnable Battle presentation
Food Safety Winnable Battle presentationFood Safety Winnable Battle presentation
Food Safety Winnable Battle presentation
 
Pandemic Flu Health Information and Work Flow Project - Sunil Nair Health Inf...
Pandemic Flu Health Information and Work Flow Project - Sunil Nair Health Inf...Pandemic Flu Health Information and Work Flow Project - Sunil Nair Health Inf...
Pandemic Flu Health Information and Work Flow Project - Sunil Nair Health Inf...
 
PERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPE
PERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPEPERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPE
PERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPE
 
09-rwcc18-sherman-keyslides.pptx
09-rwcc18-sherman-keyslides.pptx09-rwcc18-sherman-keyslides.pptx
09-rwcc18-sherman-keyslides.pptx
 
January 2010 Selected Zoonotic Diseases Conference Call
January 2010 Selected Zoonotic Diseases Conference Call January 2010 Selected Zoonotic Diseases Conference Call
January 2010 Selected Zoonotic Diseases Conference Call
 
Intro to Infectious Diseases and Epidemiology of Nosocomial Infection
Intro to Infectious Diseases and Epidemiology of Nosocomial InfectionIntro to Infectious Diseases and Epidemiology of Nosocomial Infection
Intro to Infectious Diseases and Epidemiology of Nosocomial Infection
 
CDC July 2009 Selected Zoonotic Diseases Conference Call
CDC July 2009 Selected Zoonotic Diseases Conference CallCDC July 2009 Selected Zoonotic Diseases Conference Call
CDC July 2009 Selected Zoonotic Diseases Conference Call
 
World AIDS Day 2014 HIV and AIDS Awareness Campaigns
World AIDS Day 2014 HIV and AIDS Awareness CampaignsWorld AIDS Day 2014 HIV and AIDS Awareness Campaigns
World AIDS Day 2014 HIV and AIDS Awareness Campaigns
 
Batten oss 727 -bw changes
Batten oss 727 -bw changesBatten oss 727 -bw changes
Batten oss 727 -bw changes
 
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
Durhane Wong-Rieger (CORD) Canada's Rare Disease Strategy Brief Overview
 
Tackling the U.S. Healthcare System’s Infectious Disease Management Problem
Tackling the U.S. Healthcare System’s Infectious Disease Management ProblemTackling the U.S. Healthcare System’s Infectious Disease Management Problem
Tackling the U.S. Healthcare System’s Infectious Disease Management Problem
 
Dr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
Dr. James Hughes - Combating Antimicrobial Resistance: The Way ForwardDr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
Dr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
 
When reducing cancer risk in our population, let’s not exacerbate disparities
When reducing cancer risk in our population, let’s not exacerbate disparitiesWhen reducing cancer risk in our population, let’s not exacerbate disparities
When reducing cancer risk in our population, let’s not exacerbate disparities
 
JTC300_Final Report_Goin
JTC300_Final Report_GoinJTC300_Final Report_Goin
JTC300_Final Report_Goin
 
GUH_ALICE_-_Indiana_Leadership_Conference.ppt
GUH_ALICE_-_Indiana_Leadership_Conference.pptGUH_ALICE_-_Indiana_Leadership_Conference.ppt
GUH_ALICE_-_Indiana_Leadership_Conference.ppt
 
Trend & Strategies for Prevention of Healthcare-associated Infections
Trend & Strategies for Prevention of Healthcare-associated InfectionsTrend & Strategies for Prevention of Healthcare-associated Infections
Trend & Strategies for Prevention of Healthcare-associated Infections
 
The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 

August 2009 CDC Selected Zoonotic Diseases Conference Call

  • 1. Selected Zoonotic Diseases Conference Call August 5, 2009
  • 2. Pierre Rollin, MD; Division of Viral and Rickettsial Diseases, CDC; 404-639-1124; prollin@cdc.gov Selected Zoonotic Diseases Conference Call August 5, 2009 Update: Ebola-Reston in the Philippines
  • 3. Kendra E. Stauffer, DVM; Division of Foodborne, Bacterial, and Mycotic Diseases, CDC; 404-639-3435; kstauffer@cdc.gov Selected Zoonotic Diseases Conference Call August 5, 2009 The Changing Face of Brucellosis in the United States
  • 4. Kelly K. Stimpert, MPH, PhD candidate; Division of Parasitic Diseases; 770-488-4968; kkstimpert@cdc.gov Selected Zoonotic Diseases Conference Call August 5, 2009 Update on Chagas disease in the United States
  • 5. Update on Chagas Disease in the United States Kelly Stimpert, MPH [email_address] AREF Health Communication Specialist Centers for Disease Control and Prevention Division of Parasitic Diseases
  • 6.
  • 7. Trypanosoma cruzi lifecycle
  • 8.
  • 9.
  • 10.
  • 11. Source: Schmunis Mem Inst Osw Cruz 2007 18 million people in the U.S. born in Mexico, Central and South America
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27. World Rabies Day: Why is it so important?
  • 28.  
  • 29.  
  • 30.
  • 32.
  • 33.
  • 34. Howard Pue, DVM, MSVPM; State Public Health Veterinarian, Missouri; 573-751-6117; howard.pue@dhss.mo.gov Selected Zoonotic Diseases Conference Call August 5, 2009 Missouri Rabies/Tetanus Symposium
  • 35. Emily Zielinski-Gutierrez, MPH, DRPH; Division of Vector-borne Infectious Diseases, CDC; 970-221-6477; EZielinskiGutierrez@cdc.gov Selected Zoonotic Diseases Conference Call August 5, 2009 Update: West Nile
  • 36. Selected Zoonotic Diseases Conference Call August 5, 2009

Editor's Notes

  1. .